Qualia Senolytic for Inflammation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how Qualia Senolytic, a potential anti-inflammatory therapy, might reduce inflammation in the body. Participants will take the treatment for a week and provide two blood samples from home to track changes. Individuals who are generally healthy, aged 45 to 79, and comfortable using a finger-prick test at home may be suitable candidates. The goal is to gather real-world evidence on the treatment's impact on health indicators. As an unphased trial, this study allows participants to contribute to groundbreaking research and potentially gain early insights into innovative health solutions.
Do I need to stop taking my current medications for the trial?
The trial requires that you continue taking any supplements you are currently using regularly, but you cannot start any new ones. If you are taking MAO inhibitors, SSRIs, or any psychiatric or neurological medicines, you cannot participate in the trial.
Is there any evidence suggesting that Qualia Senolytic is likely to be safe for humans?
Research has shown that Qualia Senolytic is generally safe. Most studies on its ingredients have found few or no side effects. Early data from similar treatments also suggest good tolerance. However, experts advise caution with over-the-counter supplements targeting "zombie cells" (old cells that don't die when they should). While this treatment appears promising, understanding these findings and consulting a healthcare provider if concerns arise is important.12345
Why are researchers excited about this trial?
Qualia Senolytic is unique because it targets senescent cells, which are often called "zombie cells" because they hang around and cause inflammation without dying off like normal cells. Unlike standard anti-inflammatory treatments that just manage symptoms, this approach could potentially remove the root cause of inflammation. Researchers are excited about this because it could lead to more effective and longer-lasting relief from inflammation, offering a fresh angle compared to traditional therapies.
What evidence suggests that Qualia Senolytic might be an effective treatment for inflammation?
Research has shown that Qualia Senolytic can reduce joint pain and improve joint function. In one clinical trial, participants experienced a 68% decrease in joint pain and a 66% improvement in joint function. Another study found that it significantly reduced joint problems compared to a placebo. These findings suggest that Qualia Senolytic may benefit those with joint pain and function issues. However, results can vary for each person, and consulting a doctor before starting any new treatment is advisable.12367
Are You a Good Fit for This Trial?
Adults aged 45-79 in the U.S., who are willing to use an at-home finger-prick kit and complete surveys, can join this study. They must be healthy, not pregnant or planning pregnancy, without major psychiatric, neurological, endocrine disorders or cancer. Participants should not start new supplements during the trial.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Qualia Senolytic supplementation and provide blood samples via an at-home finger-prick kit at baseline and day 7, and complete electronic surveys on health indicators at baseline, and days 3 and 7.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Qualia Senolytic
Find a Clinic Near You
Who Is Running the Clinical Trial?
Qualia Life Sciences
Lead Sponsor